Antonio Linares
@alc2022
100x investor, bio/acc. do your own research. Early $AMD, $TSLA, $PLTR, $SPOT, $HIMS, $DUOL, $IBRX, $NAUT.
加入 November 2020
410 正在關注 163.7K 粉絲
Peptides are a write function. Biology is code.
The winner won’t be whoever makes the molecule.
It’ll be whoever owns the patient data and the AI that matches each person to the optimal write function.
That’s $HIMS.
顯示更多
everyone gave up on $HIMS in february 2026
the stock is up ~3X since
$hims is a not a GLP-1 company, but a Healthcare Ontology
$2,000/share intrinsic value by the year 2030
